SBC Medical Reports Strong Q3 2026 Growth Driven by Fee Revisions and Segment Consolidation
SBC Medical Group Holdings reported robust third-quarter 2026 financial results, highlighted by a 35% year-over-year increase in total revenue to $59 million. This growth was primarily fueled by strategic revisions to management service fee structures implemented in August 2026 and the successful consolidation of the Waqoo segment into the group's operations. Profitability metrics showed significant expansion, with income from operations rising 66% to $26 million and Adjusted EBITDA margins reaching 47%. The company benefited from operating leverage following structural reforms conducted in 2025. Despite intense competition in the Japanese market causing some smaller competitors to close, SBC Medical expanded its clinic network to 293 locations and continues to scale its U.S. presence through the OrangeTwist network.
Topics: clinic network expansion EBITDA margin expansion EPS increase revenue growth